THE EFFECT OF FASTING AND/OR BODY-WEIGHT REDUCTION ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1)

被引:7
|
作者
PETERNEL, P
STEGNAR, M
MAVRI, A
SALOBIRPAJNIC, B
机构
[1] University Medical Centre, Trnovo Hospital of Internal Medicine, Ljubljana
关键词
FAST; WEIGHT REDUCTION; FIBRINOLYTIC ACTIVITY; SERUM LIPIDS;
D O I
10.1016/0268-9499(94)90240-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ten healthy, physically fit, non-smoking volunteers (9 women, 1 man, aged 22-55, mean 33 years) with normal body weight and blood lipids were included in the study. During a fasting period of 8-21 (mean 16) days they took only drinks and lost 5-12 (mean 7) kg of body weight. Resting and post-20 min upper arm venous occlusion blood samples were obtained 1-2 days before and on the last day of the fast. Fasting did not significantly affect blood lipids. After fasting an increase in testing euglobulin activity (7.4 vs 3.6 mid(-1), p < 0.01), and in tissue-type plasminogen activator (t-PA) activity (215 vs 42 mIU/ml, p < 0.01) was found. A decrease in plasminogen activator inhibitor (PAT) activity (5.5 vs 7.1 IU/ml, p < 0.07) was indicated, while changes in t-PA and PAI-1 antigens were not significant. After the fast fibrinolytic response to venous occlusion was enhanced as observed by greater increase in euglobulin activity (40.4 vs 11.6 min(-1), p < 0.02), t-PA activity (30754 vs 1593 mIU/ml p < 0.01), t-PA antigen (25.9 vs 11.6 ng/ml, p < 0.02), and greater decrease in PAT activity (3.5 vs 0.0 IU/ml, p < 0.01). In ten non-fasting subjects on normal diet, repeated measurements in a period of 13-23 (mean 17) days revealed no significant changes either before or after venous occlusion, It was concluded that in physically fit, non-obese subjects fasting and/or body weight reduction has enhancing effect on resting and post-venous occlusion fibrinolytic activity without significant changes in blood lipids.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
  • [1] INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AND TISSUE PLASMINOGEN-ACTIVATOR (T-PA) ON FIBRIN
    WAGNER, OF
    HOHMANN, C
    VEERMAN, H
    DEVRIES, C
    VOORN, P
    LAMBERS, H
    KLEINGEBBINK, R
    EHRLICH, HJ
    PANNEKOEK, H
    BLUT, 1988, 57 (04): : 184 - 184
  • [2] EFFECT OF ISOTRETINOIN ON ENDOGENOUS TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN HUMANS
    WALLNOFER, AE
    VANGRIENSVEN, JMT
    SCHOEMAKER, HC
    COHEN, AF
    LAMBERT, W
    KLUFT, C
    MEIJER, P
    KOOISTRA, T
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (06) : 1005 - 1008
  • [3] ON THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) - EFFECT OF VITRONECTIN
    KEIJER, J
    EHRLICH, HJ
    LINDERS, M
    PREISSNER, KT
    PANNEKOEK, H
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 859 - 859
  • [4] TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AFTER KIDNEY-TRANSPLANTATION
    VOLK, C
    LORETH, RM
    ALBERT, FW
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1335 - 1335
  • [5] EVALUATION OF BLOOD-SAMPLING FOR THE MEASUREMENT OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY (PAI-1)
    VANDERHEIDE, YT
    MORRIEN, W
    VANDENENDE, A
    FIBRINOLYSIS, 1994, 8 : 152 - 153
  • [6] MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN HUMAN PLASMA
    ALESSI, MC
    JUHANVAGUE, I
    DECLERCK, PJ
    COLLEN, D
    THROMBOSIS RESEARCH, 1991, 62 (04) : 275 - 285
  • [7] EFFECT OF DEXTRAN ON PLASMA TISSUE PLASMINOGEN-ACTIVATOR (T-PA) AND TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) DURING SURGERY
    ERIKSSON, M
    SALDEEN, T
    WALLIN, R
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 394 - 394
  • [9] QUANTIFICATION OF THE SPECIFIC INHIBITOR (PAI-1) OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) IN PLASMA
    MASSON, C
    ANGLESCANO, E
    ANNALES DE BIOLOGIE CLINIQUE, 1989, 47 (05) : 269 - 274
  • [10] THE ROLE OF THE FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN INITIATION AND PROGRESSION OF THROMBOLYSIS
    STRINGER, HAR
    VANSWIETEN, P
    HORREVOETS, AJG
    SMILDE, A
    PANNEKOEK, H
    THROMBOSIS AND HAEMOSTASIS, 1994, 72 (06) : 900 - 905